Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Sumitomo Chemical India Ltd

SUMICHEM
NSE
436.40
1.04%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Alert
Watchlist
Note

Sumitomo Chemical India Ltd

SUMICHEM
NSE
436.40
1.04%
29 Apr '26, 4:00 PM
Company Overview
Guidance Tracker
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
21,783Cr
Close
Close Price
436.40
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
40.98
PS
Price To Sales
6.74
Revenue
Revenue
3,234Cr
Rev Gr TTM
Revenue Growth TTM
2.89%
PAT Gr TTM
PAT Growth TTM
2.88%
Peer Comparison
How does SUMICHEM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SUMICHEM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
6527249035426748399886426791,057930568
Growth YoY
Revenue Growth YoY%
-2.0-26.5-19.4-28.03.515.89.418.40.826.0-5.9-11.5
Expenses
ExpensesCr
571644716476534678743536560838712468
Operating Profit
Operating ProfitCr
81811886614016124510612021921899
OPM
OPM%
12.411.120.812.120.819.224.816.517.620.723.417.5
Other Income
Other IncomeCr
161825272726313132393921
Interest Expense
Interest ExpenseCr
111111122222
Depreciation
DepreciationCr
141416161715161916161717
PBT
PBTCr
828319575149171260117133241238102
Tax
TaxCr
102252213944672933636026
PAT
PATCr
7262143551101271938710017817876
Growth YoY
PAT Growth YoY%
-3.4-55.4-28.8-39.552.4105.434.259.8-9.240.6-7.7-13.3
NPM
NPM%
11.18.515.910.116.315.119.513.614.716.919.113.3
EPS
EPS
1.41.22.91.12.22.53.91.72.03.63.61.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,9132,2122,4252,6453,0613,5112,8443,1493,234
Growth
Revenue Growth%
15.69.69.115.714.7-19.010.72.7
Expenses
ExpensesCr
1,6961,9482,0922,1582,4612,8442,3692,5162,578
Operating Profit
Operating ProfitCr
217264333487600667475632656
OPM
OPM%
11.311.913.718.419.619.016.720.120.3
Other Income
Other IncomeCr
3028-2019274596120130
Interest Expense
Interest ExpenseCr
346665568
Depreciation
DepreciationCr
242841474552626666
PBT
PBTCr
221260267453576654503680713
Tax
TaxCr
769462108152152133174182
PAT
PATCr
145166205345424502370506531
Growth
PAT Growth%
14.323.568.722.618.6-26.437.04.9
NPM
NPM%
7.67.58.413.113.814.313.016.116.4
EPS
EPS
2.93.34.16.98.510.17.410.110.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
275275499499499499499499499
Reserves
ReservesCr
6797747231,0421,4281,8831,9422,4022,698
Current Liabilities
Current LiabilitiesCr
6727768401,0811,0219338019651,136
Non Current Liabilities
Non Current LiabilitiesCr
3335455061546894102
Total Liabilities
Total LiabilitiesCr
1,6581,8602,1062,6723,0103,3693,3133,9644,439
Current Assets
Current AssetsCr
1,3461,5411,7462,3042,5222,7882,6733,0203,545
Non Current Assets
Non Current AssetsCr
313319361368488581640944894
Total Assets
Total AssetsCr
1,6581,8602,1062,6723,0103,3693,3133,9644,439

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
4778221425222389757453
Investing Cash Flow
Investing Cash FlowCr
-40-35-118-283-290-327-420-392
Financing Cash Flow
Financing Cash FlowCr
7-65-61-47-63-73-337-69
Net Cash Flow
Net Cash FlowCr
15-234296-131-100-8
Free Cash Flow
Free Cash FlowCr
439184383109270695424
CFO To PAT
CFO To PAT%
32.746.9108.2123.252.477.5204.889.4
CFO To EBITDA
CFO To EBITDA%
21.929.566.587.437.058.4159.671.6

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
009,15714,51522,43921,22617,34027,890
Price To Earnings
Price To Earnings
0.00.044.742.053.042.347.055.2
Price To Sales
Price To Sales
0.00.03.85.57.36.06.18.9
Price To Book
Price To Book
0.00.07.59.411.68.97.19.6
EV To EBITDA
EV To EBITDA
-0.3-0.127.329.437.331.436.244.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.234.033.737.437.735.337.641.0
OPM
OPM%
11.311.913.718.419.619.016.720.1
NPM
NPM%
7.67.58.413.113.814.313.016.1
ROCE
ROCE%
23.224.721.629.229.627.320.623.2
ROE
ROE%
15.215.816.822.422.021.115.117.5
ROA
ROA%
8.88.99.712.914.114.911.212.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Sumitomo Chemical India Ltd. (SCIL) is a leading Indian agrochemical company and the flagship entity of the global Sumitomo Chemical Company (SCC) Group, Japan. With over two decades of operations in India, SCIL has established itself as a key player in the crop protection, environmental health, and animal nutrition sectors. Backed by strong R&D capabilities, backward integration, a robust distribution network, and digital innovation, SCIL combines global scale with localized market execution to deliver sustainable, eco-friendly solutions to Indian and international farmers. --- ### **Core Strengths & Strategic Positioning** #### **1. Market Leadership and Diversified Portfolio** - SCIL holds a dominant position in the Indian agrochemical market, with leadership across both product categories and manufacturing processes. - The company offers a balanced and diversified portfolio spanning **insecticides, herbicides (weedicides), fungicides, fumigants, rodenticides, plant growth regulators (PGRs), bio-rationals, and nutrients**, serving over **200 brands and 700+ SKUs**. - It is one of the few Indian companies offering both **chemical and biological crop protection products**, giving it a competitive edge in the shift toward sustainable agriculture. - No single product or molecule contributes more than **~15% of revenue**, and the top 10 products account for **less than 45% of total revenue**, reducing dependency and enhancing resilience. - The portfolio is strategically aligned with high-growth, high-margin segments: **herbicides, PGRs, and bio-rational products**, with deliberate efforts to expand PGR offerings for both **Kharif and Rabi seasons** to reduce seasonality. #### **2. Manufacturing & Backward Integration** - SCIL operates **five state-of-the-art manufacturing facilities** across Gujarat, Maharashtra, and Silvassa – at **Bhavnagar (~58 acres), Gajod (~120 acres), Tarapur (~5 acres), Vapi (~6 acres), and Silvassa (~3 acres)** – totaling **~190 acres** of production land. - These strategically located plants specialize in **technical-grade pesticides (TGAI), formulations, metal phosphides, and water-dispersible granules (WDG)**, with 80–90% capacity utilization. - Key products include **glyphosate, chlorpyrifos, imidacloprid, tebuconazole, aluminum phosphide,** and **sulfur WDG**. - The company has significant **backward integration capabilities**, particularly in active ingredient manufacturing, reducing import dependence and improving cost control. #### **3. Global R&D Powerhouse & Innovation** - SCIL leverages the **global R&D and supply chain capabilities** of its parent, SCC Japan, while maintaining strong in-house innovation in India. - It operates **three DSIR-approved R&D laboratories** in **Mumbai, Bhavnagar, and Gajod**, staffed by **over 75 scientists and engineers**, including **30+ PhDs**. - Focus areas include **off-patent products, novel formulations, combination products, reduced toxicity solutions**, and **green chemistry**. - The company has filed **over 25 patents globally**, with five patent applications in progress, and holds more than **200 product registrations**. - SCIL is actively developing **proprietary molecules from SCC Japan** for local manufacturing under the **"Make in India" initiative**, positioning itself as a global manufacturing hub. --- ### **Growth Drivers & Expansion Strategy** #### **1. Greenfield & Brownfield Expansions (Dahej & Tarapur)** - A **50-acre freehold land parcel** has been acquired at **Dahej PCPIR** for a **large-scale Greenfield manufacturing project**, with environmental clearance secured. - The Dahej project will house multiple plants for **SCC-innovated proprietary molecules and intermediates**, supported by a **10-year environmental license**. - A **second plant for a key SCC-innovated product** is being established at **Bhavnagar**, and a **brownfield expansion at Tarapur** will produce a new global blockbuster molecule. - The Tarapur Brownfield project (CAPEX < ₹10 crore) aims to meet **100% of domestic demand** within two years and serve as a bridge until Dahej plants are operational. #### **2. Capital Investment & CAPEX Outlook** - **Regular CAPEX**: ₹70–75 crore/year for maintenance, efficiency, and upgrades. - **Strategic CAPEX**: - ₹120–300 crore invested in proprietary molecule production projects. - ₹55 crore approved to double capacity of an existing high-utilization plant for export. - Focus on **backward integration, capacity expansion, digital infrastructure, and sustainability (GX & DX)**. #### **3. Export Growth & Global Footprint** - Exports reach **over 50 countries** across **Latin America, Africa, Asia Pacific, Europe, Middle East, and North America**. - Exports contribute **~30–35% of total revenue**, with growth driven by **off-patent molecules, bulk technical-grade supplies, and proprietary formulations**. - **Synergies with Sumitomo Chemicals Latin America (SCLA)** enable stronger market penetration. - The company is evaluating registration of existing brands for **European markets**, with bioproducts showing strong potential. --- ### **Digital & Sustainable Transformation (DX & GX)** #### **Digital Transformation (DX) – “Phygital” Engagement** - SCIL has pioneered a **phygital (physical + digital)** model to engage rural India’s **442 million internet users** and **425 million smartphone owners**. - Key digital initiatives: - **814 localized, voice-search-optimized landing pages** in regional dialects. - **639 precision-targeted digital campaigns** aligned with crop cycles and regional needs. - **14.2 crore digital touchpoints** generated, reducing marketing costs by **17.2%** via programmatic ad delivery. - 23 websites in 9 languages; over **53,000 YouTube subscribers**; 100s of live sessions on YouTube, Facebook, Zoom. - **"Every Day Farmer’s Day" (EDFD)** – a grassroots outreach program – has engaged **over 1 million farmers and thousands of channel partners**. #### **Field Activity Tracking & Digital Field Days** - Two proprietary apps – **Sumitomo Connect** and **Sumitomo Field Connect** – track field activities in real time. - **“Phygital” Field Days** combine on-ground demonstrations with **live digital interactions involving agronomists, R&D teams, and farmers**, enhancing trust and feedback loops. #### **Green Transformation (GX)** - **Renewable Energy**: **38% of energy needs** met via **solar and wind projects**, with plans to increase this share. - **Sustainability Leadership**: Offers **one of the highest shares of environmentally friendly products** in the industry. - Focus on **eco-friendly formulations, bio-rationals, and low-toxicity products** under the Custom Solutions Division. --- ### **Strategic Acquisitions & Collaborations** #### **Acquisition of Barrix Agro Sciences (Dec 2023)** - Acquired **85% stake** in Bengaluru-based **Barrix Agro Sciences**, a leader in **Integrated Pest Management (IPM)** and **Integrated Plant Nutrition Management (IPNM)**. - Barrix specializes in **pheromone traps, chromatic sheets, and green dispersion technologies**. - In FY25, Barrix achieved **82% revenue growth** and turned **EBITDA profitable at 16%**, validating successful integration. - This move strengthens SCIL’s leadership in **bio-solutions** and supports SCC Japan’s global **green chemistry strategy**. #### **Marketing Global Brands in India** - SCIL is the **exclusive domestic marketer** for: - Proprietary agrochemicals, animal nutrition, and environmental health products of **Sumitomo Chemical Company, Japan**. - Products from **Valent Bio-Sciences (US-based affiliate)**, including **bio-stimulants and growth regulators**. --- ### **Financial & Operational Performance** - Achieved **highest profitability in FY2024–25** in terms of **PAT and EBITDA margins** despite global headwinds. - Domestic growth driven by **strong crop seasons, digital campaigns, and new product launches**. - Export growth sustained via **volume gains and expanded registrations**, particularly in **Africa and Latin America**. - Inventory optimization completed by **Jul 2024**, normalizing margins post high-cost carryover. --- ### **Recent Product Launches & Pipeline** - **New domestic launches in FY25–26** include: - **INDIFLIN (marketed as Excalia Max)** – a patented, high-potential molecule from SCC. - **Lentigo**, a next-gen herbicide for rice. - **Meshi, Portion, Ormie, Pyclome, Danitol NXT**, and **Sumiblue Diamond**. - **Registration secured** for two novel herbicides: **Excalia Max** and **Lentigo**. - Pipeline includes **3–4 new products** under the **9(4) registration framework**, with focus on **high-efficacy, low-toxicity, eco-friendly formulations**. --- ### **Key Milestones in 2024–25** - **25th Anniversary** of SCIL in India (FY2024–25). - Commenced commercial sales from **two new manufacturing plants**, focusing on **global proprietary molecules**. - Successfully launched **multiple phygital campaigns** and scaled up **digital engagement** to **22–23 million farmers**. - Achieved **debt-free status**, with strong return ratios and robust operational margins.